Bacillus cereus, a serious cause of nosocomial infections: Epidemiologic and genetic survey.
Benjamin GlassetSabine HerbinSophie A GranierLaurent CavaliéEmilie LafeuilleCyprien GuérinRaymond RuimyFlorence Casagrande-MagneMarion LevastNathalie ChautempsJean-Winoc DecousserLaure BelottiIsabelle PellouxJerôme RobertAnne BrisaboisNalini RamaraoPublished in: PloS one (2018)
Bacillus cereus is the 2nd most frequent bacterial agent responsible for food-borne outbreaks in France and the 3rd in Europe. In addition, local and systemic infections have been reported, mainly describing individual cases or single hospital setting. The real incidence of such infection is unknown and information on genetic and phenotypic characteristics of the incriminated strains is generally scarce. We performed an extensive study of B. cereus strains isolated from patients and hospital environments from nine hospitals during a 5-year study, giving an overview of the consequences, sources and pathogenic patterns of B. cereus clinical infections. We demonstrated the occurrence of several hospital-cross-contaminations. Identical B. cereus strains were recovered from different patients and hospital environments for up to 2 years. We also clearly revealed the occurrence of inter hospital contaminations by the same strain. These cases represent the first documented events of nosocomial epidemy by B. cereus responsible for intra and inter hospitals contaminations. Indeed, contamination of different patients with the same strain of B. cereus was so far never shown. In addition, we propose a scheme for the characterization of B. cereus based on biochemical properties and genetic identification and highlight that main genetic signatures may carry a high pathogenic potential. Moreover, the characterization of antibiotic resistance shows an acquired resistance phenotype for rifampicin. This may provide indication to adjust the antibiotic treatment and care of patients.
Keyphrases
- end stage renal disease
- healthcare
- chronic kidney disease
- newly diagnosed
- ejection fraction
- genome wide
- peritoneal dialysis
- risk assessment
- escherichia coli
- prognostic factors
- adverse drug
- gene expression
- palliative care
- cross sectional
- mycobacterium tuberculosis
- copy number
- cystic fibrosis
- patient reported outcomes
- multidrug resistant
- social media
- staphylococcus aureus
- patient reported
- pulmonary tuberculosis
- quality improvement
- health information